Pfizer reported strong quarterly results and raised its 2021 guidance for covid-19 vaccine sales by a wide margin. The company made a number of announcements that could lead to a spike in demand for its covid-19 vaccine.
Pfizer reported strong quarterly results and raised its 2021 guidance for covid-19 vaccine sales by a wide margin. The company made a number of announcements that could lead to a spike in demand for its covid-19 vaccine.